NL-OMON28108尚未招募不适用
Phase II study with oral fibroblast growth factor-1 inhibitor BIBF1120 as second line treatment in lung carcinoma patients harboring fibroblast growth factor receptor-1 gene amplification (NVALT15)
ederlandse Vereniging van Artsen voor Longziekten en Tuberculose NVALT (dutch society of pulmonary physicians)0 个研究点目标入组 80 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 发起方
- 入组人数
- 80
研究概览
简要总结
one
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Stage IIIB or IV after failure of first line treatment or recurrent NSCLC haboring a positive FISH for FGFR1 amplification.
- •Age ≥ 18 years.
排除标准
- •Other investigational drugs or treatment in another clinical trial within the past 4 weeks.
- •Chemo-, hormone-, immunotherapy or therapy with monoclonal antibodies or small tyrosine kinase inhibitors within the past 4 weeks.
研究者
相似试验
已完成
2 期
Phase II study with oral fibroblast growth factor-1 inhibitor BIBF1120 as treatment in lung carcinoma patients harboring fibroblast growth factor receptor-1 gene amplification (NVALT-15 study)NSCLClung cancerNL-OMON44999Stichting NVALT studies40
进行中（未招募）
1 期
Study with BIBF1120 in lung canger patients with an abnormal fibroblast growth factor-1 receptor (NVALT-15 study)on small cell lung cancerMedDRA version: 20.0Level: PTClassification code 10029522Term: Non-small cell lung cancer stage IVSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 20.0Level: PTClassification code 10029521Term: Non-small cell lung cancer stage IIIBSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2013-004324-11-NLStichting NVALT studies76
进行中（未招募）
1 期
Study with BIBF1120 in lung canger patients with an abnormal fibroblast growth factor-1 receptor (NVALT-15 study)on small cell lung cancerMedDRA version: 17.1 Level: PT Classification code 10029522 Term: Non-small cell lung cancer stage IV System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 17.1 Level: PT Classification code 10029521 Term: Non-small cell lung cancer stage IIIB System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2013-004324-11-ESStichting NVALT studies80
已完成
1 期
Gefitinib and Radiation Therapy in Treating Patients With Glioblastoma MultiformeAdult Giant Cell GlioblastomaAdult GlioblastomaAdult GliosarcomaNCT00052208National Cancer Institute (NCI)158
已完成
2 期
Fibroblast Growth Factor Regeneration of Tympanic Membrane PerforationsTympanic Membrane PerforationNCT04960384NYU Langone Health52